A real-world study of adverse drug reactions of two isocitrate dehydrogenase inhibitor based on the US FDA adverse event reporting system and VigiAccess databases
Based on the current comparative observational studies, the ADR reports received by the World Health Organization, Food and Drug Administration for these drugs list common and specific adverse drug reactions. Clinical doctors should develop individualized treatment plans based on the adverse reactions of different drugs and the specific conditions of patients to promote the rational use of these expensive medications.
Authors
- Manjuan Li
- Xuemian Lu (ORCID: https://orcid.org/0000-0002-2277-0052)
- Qian Guo (ORCID: https://orcid.org/0000-0002-1211-6436)
- Mengmeng Peng (ORCID: https://orcid.org/0000-0003-4528-6981)
- Baiquan Zhang
- Zixuan Wang (ORCID: https://orcid.org/0009-0009-9134-4952)
- Jie Lin (ORCID: https://orcid.org/0000-0003-3784-8120)
- Zihan Dang
Institutions
- Wenzhou Medical University (CN)
- Ruian People's Hospital (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Columbia University (US)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-11-07
- DOI
- https://doi.org/10.3389/fphar.2024.1489045
- Citations
- 3
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 1.17